"In order to ensure that our products are not misused for lethal purposes, we currently require our customers to certify that they will prohibit the use and sale of such products to other customers and members that may administer lethal injections or which may sell to facilities that administer lethal injections," a Sun Pharma spokesperson told PTI.
The spokesperson was reacting to a media report that a drug sold by Sun Pharma could be used for executions by the State of Arkansas.
According to a media report, the Arkansas Department of Correction purchased three drugs, including one of Sun Pharma, which were enough to perform eight executions.
As per the Associated Press report, the drug from Sun Pharma was vercuronium bromide, a paralytic and muscle relaxant.
The other two companies whose products were purchased for the executions are Hospira Inc and London-based Hikma Pharmaceuticals, the report added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
